By Rory McCann, Marketing Manager & Conference Producer, LSN
The application deadline to pitch at RESI Partnering Week, September 13-17 is around the corner. Submit your application to pitch directly to a panel of relevant investors by August 20. Applications are accepted on a rolling basis.
The Innovator’s Pitch Challenge (IPC) provides an opportunity for life science startups to pitch directly to a panel of investors during a live Q&A session, providing valuable insights and feedback. Participants build connections between fundraising founders and potential investors on the panel and in the audience.
Participating companies receive:
- A dedicated page showcasing a pre-recorded pitch video, pitch deck, and executive summary
- A spot in the live pitch session and Q&A with investors actively seeking assets in their sector
- Global visibility to partners that are a fit for their stage of development and product
- Increased global footprint, opportunities to engage with global partners, and valuable, insightful feedback
Hear from recent IPC winners, see what investors have to say, and sign up today to pitch at RESI Partnering Week!
See What Investors Are Saying about The Innovator’s Pitch Challenge
 “It was a very economical use of time; the investors got to ask their important questions and the Innovators got a good idea of the most pressing questions from the investors point of view.”William Kuziel, MedPro Investors
 “The Pitch Sessions are a great opportunity to connect with startup CEOs and learn more about their work…It really has been an effective and efficient way to make connections, create deal flow and help startups raise money for their upcoming raises.”Mayank Taneja, OSF Healthcare
 “I look forward to LSN’s events because they provide an opportunity for our venture capital firm to find promising companies with exceptional technologies. The organization and technology platform make it very easy to hear numerous pitches from founders.”Nat Brinn, VC23
 “The Pitch Sessions were a great opportunity to engage with the CEO/Founders of very innovative Life Science startups. Despite the COVID-related transition from in-person to virtual meetings, the RESI team did an outstanding job organizing these sessions, ensuring that the live Q&A was very productive, and facilitating follow-up with these exciting companies.”Gary Gershony, Life Science Angels / BayMed Venture Partners
|
Next Phase Newsletter 
Leave a Reply